本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

220.93
-8.4500-3.68%
盘后220.930.00000.00%19:52 EDT
成交量:45.89万
成交额:1.03亿
市值:137.67亿
市盈率:-50.01
高:231.78
开:229.38
低:220.66
收:229.38
52周最高:250.74
52周最低:150.89
股本:6,231.61万
流通股本:6,008.34万
量比:0.39
换手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
净资产收益率:-818.43%
总资产收益率:-6.86%
市净率:-72.09
市盈率(LYR):-50.01

数据加载中...

2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]